Responsible for the promotion of the atypical antipsychotic Abilify for approved indications to Psychiatrists and Internal Medicine physicians.Through August 2014 sales goal attainment for Abilify is 102.57%. In 2013 achieved a ranking of 6 out of 31 with a goal attainment of 100.14% in the New England region.

Hospital Representative) – Queens/Western Nassau County Raised ranking of territory from 62 out of 67 in January 2012 to 13 out of 67 by June 2012 through strategic focus of product resources such as speaker programs, webinars and patient assistance programs. Recipient of the Vice President’s Cabinet Award for Outstanding Sales Achievement in 2010. This award is given to the top eight percent of the sales representatives in the country.In March 2012 launched new indication for Prevnar 13 vaccine in a satisfied market. Since the launch in March there have been three formulary approvals in three key accounts. Appointed District Operations Expert in January 2012. Responsibilities included navigating, understanding and presenting to district a new business planning document as well as a new hospital and retail sales report.Chosen to rollout a key pilot initiative in 2011 for lead product Zyvox that led to removal of barriers to access in local retail pharmacies. Managed a portfolio of five products (Zyvox, Tygacil, Vfend, Relistor, and Prevnar 13) over the last 3 years that were sold to various specialties including: Infectious Disease, Critical Care/ Pulmonary Medicine, Oncology, General Surgery, Podiatry/Wound Care, Emergency Medicine, Hospitalists, Gastroenterology and Case Managers.Developed relationship with a key physician assistant contact that has allowed access to and display opportunities at the New York State Society of Physician Assistant (NYSSPA) meetings. Ownership of the quarterly meetings for the Long Island Infectious Disease Society meetings. This has allowed for increased selling time as well as developing new relationships and building upon existing relationships with key members.Current territory includes both academic and community hospitals. North Shore Manhasset, Long Island Jewish Medical Center, New York Hospital Queens, Flushing Hospital, Forest Hills Hospital and Franklin Hospital.

Responsible for developing key opinion leaders for the antibiotics Zosyn and Tygacil. Three of these key opinion leaders became advisors to the Tygacil marketing team resulting in the creation of an antibiotic stewardship lecture series.Discussed and reinforced the concept of antibiotic stewardship within the major medical centers and community hospitals. This led to goal attainment in excess of 100% for both Tygacil and Zosyn in 2008.Leveraged relationships with the Microbiology Departments that allowed for obtaining pertinent information regarding resistance challenges in the hospital. This created increased access to the Infectious Disease physicians and allowed for more productive discussions and increased the appropriate use of the antibiotic portfolio.Negotiated profitable pricing contracts with the hospital and hospital system procurement departments. Managed portfolio of five products that were promoted to various specialties which included Infectious Disease, Critical Care/Pulmonary Medicine, Oncology, Cardiology, Nephrology, Endocrinology, Hospitalists, Gastroenterology, General Surgery, Podiatry/Wound Care and Emergency Medicine.Utilized resources such as on site and off site speaker programs, webinars, and in services to breakdown access barriers in order to increase selling time with department thought leaders and decision makers.Active supporting member of the New York State Council of Health System Pharmacists (NYSCHP). Within eight months of the launch of Tygacil (July 2005), all the accounts within the territory had added it to the hospital formulary.

Expanded market share for antidepressant Effexor XR and the hypnotic Sonata across hospital and community based psychiatrists. Developed area psychiatrists as key opinion leaders presenting to psychiatrists and primary care physicians.Organized sessions with national experts; presented clinical trial data / indications, patient types, market differentiators.Analyzed competitive market share and sales data to identify / capitalize on trends; built program targeting Top 15 Prescribers to maximize Effexor XR prescriptions for patients with major depression / co-morbid anxiety symptoms. Area Field Trainer – Psychiatry Specialty Management Sales Force, 2001 Based on track record of growing sales, hand-picked to develop and present field & corporate training programs for new hires and newly promoted Psychiatry Specialty Managers (PSMs) and selected Reps.

Managed a portfolio of eleven products that were promoted to various specialties including Rheumatology, Orthopedic Surgery, Cardiology, Neurology, Pain Management, Internal Medicine and Emergency Medicine. Launched the product Enbrel in 1998 to both Rheumatology and Internal Medicine specialties. Worked with Rheumatology Specialty Manager to gain access and increase sales in key Rheumatologic accounts.Launched and promoted the device Synvisc to Orthopedic Surgeons and Rheumatologists. Through engaging in total office call from physicians to medical billing staff, sales increased dramatically in key accounts. This led to an overall rank of seven out of one hundred four in 1997.